Answers are grounded in this paper and cite their sources.
SARS-CoV-2 infection is associated with increased risk of depressive symptoms. We sought to examine associated factors of depressive symptoms approximately one year after SARS-CoV-2 infection. A survey of 528 individuals aged 16 years or older who were diagnosed with COVID-19 between 29 July 2020, and 31 March 2021 was conducted in Iwate Prefecture, Japan. The survey was administered from 15 November to 15 December 2021 (response rate, 40.9%). After excluding participants with incomplete responses, 151 respondents were included in the analytical sample. Depressive symptoms during the last week was assessed by the Japanese version of the CES-D scale. We examined factors associated with depressive symptoms using logistic regression analyses. The mean follow-up was 11 months (SD 1.6; range 7–16). The prevalence of depressive symptoms was 15.9%. Individuals living alone had significantly elevated risk of depressive symptoms (odds ratio, 3.38, 95% confidence interval: 1.13–10.10). Depressive symptoms one year after SARS-CoV-2 infection was associated with social circumstances (living alone), but no other biomedical factors, such as the severity of the original disease (e.g., requiring oxygen supplementation in hospital).
No takes yet. Share an insight, caveat, or question.
Takahashi et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: